In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
SOURCE Anavex Life Sciences Corp.
TheStreet's biotech columnist offers his own report card on biotech stocks.
Biotechs were trading at high volumes Thursday morning on news that the Senate has passed the 21st Century Cures Act.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
These under-$10 stocks are within range of triggering breakout trades. Here's how to trade them from here.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.